Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

Thumbnail for Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

ABCL - 914

Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

Ali Turunc

Poster Presenter: Ali Turunc

$Thumbnail for Mezigdomide, Carfilzomib, and Dexamethasone (MeziKd) vs Carfilzomib and Dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Phase 3 SUCCESSOR-2 Trial$

MM - 569

Mezigdomide, Carfilzomib, and Dexamethasone (MeziKd) vs Carfilzomib and Dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma (RRMM): Results From the Phase 3 SUCCESSOR-2 Trial

Meletios A Dimopoulos

Poster Presenter: Meletios A Dimopoulos

$Thumbnail for Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States$

ALL - 294

Micro-Costing Analysis of Adverse Events of Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Therapy in the United States

Marleni Torres Nunez

Poster Presenter: Marleni Torres Nunez

Thumbnail for Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

CLL - 787

Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

Ahmed Qaedi

Poster Presenter: Ahmed Qaedi

Thumbnail for Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

MM - 1205

Minimal Residual Disease Negativity in Newly Diagnosed Multiple Myeloma: From Surrogate Endpoint Validation to the Unanswered Question of Maintenance-Free Remission

Sukhmani Sidhu

Poster Presenter: Sukhmani Sidhu

Thumbnail for Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

MPN - 908

Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

Ashiya Loomba

Poster Presenter: Ashiya Loomba

Thumbnail for Molecular and Pathologic Staging Gaps in Mycosis Fungoides and Sιzary Syndrome: Real-World Evidence From the LEO-MER Prospective Cohort

TCL - 1507

Molecular and Pathologic Staging Gaps in Mycosis Fungoides and Sιzary Syndrome: Real-World Evidence From the LEO-MER Prospective Cohort

Muhammad Saad Hamid

Poster Presenter: Muhammad Saad Hamid

Thumbnail for Molecular Predictors of Response to Venetoclax-Based Therapy in Acute Myeloid Leukemia

AML - 648

Molecular Predictors of Response to Venetoclax-Based Therapy in Acute Myeloid Leukemia

Tabish Siddiqui

Poster Presenter: Tabish Siddiqui

Thumbnail for Molecular Profiling of Chronic Lymphoproliferative Diseases in Brazilian Patients: A Real-World Next-Generation Sequencing Panel Experience

ABCL - 1434

Molecular Profiling of Chronic Lymphoproliferative Diseases in Brazilian Patients: A Real-World Next-Generation Sequencing Panel Experience

Andre Meireles

Poster Presenter: Andre Meireles

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.